Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02427854Not ApplicableCompleted

Palestinian Perineum and Birth Complication Study

Role: collaborator

NCT06085001Unknown

Use of Lumella-glycosylated Fibronectin for Diagnosis of Preeclampsia

Role: lead

NCT01310660Completed

Evaluation of Levator Injuries Using Transvaginal Endosonography

Role: lead

NCT02655900Completed

Use of 3D Ultrasound to Predict Anal Sphincter Defects

Role: lead

NCT02239302Completed

Obstructed Defaecation: Proctography Versus Ultrasound in Symptomatic Patients

Role: lead

NCT01321762Completed

Prolapse and Pregnancy Assessment

Role: lead

All 6 trials loaded